BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 11200600)

  • 1. [Genetic basis for dyslipidemias].
    Ruiz J
    Nephrologie; 2000; 21(7):323-5. PubMed ID: 11200600
    [No Abstract]   [Full Text] [Related]  

  • 2. Monogenic dyslipidemias: window on determinants of plasma lipoprotein metabolism.
    Hegele RA
    Am J Hum Genet; 2001 Dec; 69(6):1161-77. PubMed ID: 11704922
    [No Abstract]   [Full Text] [Related]  

  • 3. Distribution of risk factors, plasma lipids, lipoproteins and dyslipidemias in a small Mediterranean island: the Ustica Project.
    Barbagallo CM; Polizzi F; Severino M; Onorato F; Noto D; Cefalù AB; Rizzo M; Notarbartolo A; Averna MR
    Nutr Metab Cardiovasc Dis; 2002 Oct; 12(5):267-74. PubMed ID: 12616806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ubiquitous lipids and related diseases: a laboratory perspective.
    Ogedegbe HO; Brown DW
    MLO Med Lab Obs; 2001 Jul; 33(7):18-24, 26; quiz 28-9. PubMed ID: 11467171
    [No Abstract]   [Full Text] [Related]  

  • 5. Dyslipidemias associated with heterozygous lipoprotein lipase mutations in the French-Canadian population.
    Julien P; Gagné C; Murthy MR; Lévesque G; Moorjani S; Cadelis F; Hayden MR; Lupien PJ
    Hum Mutat; 1998; Suppl 1():S148-53. PubMed ID: 9452071
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of lipids, lipoproteins and apolipoproteins concentrations in cord blood serum of newborns from rural and urban environments.
    Pac-Kozuchowska E
    Ann Agric Environ Med; 2007; 14(1):25-9. PubMed ID: 17655173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nationality differences in distributions of serum lipids, lipoproteins and apolipoproteins levels in Xinjiang China.
    Zou Y; He B; Hu D; Yang X; Li X; Zhao X; Huang D; Meng Z; Shagendeke
    Chin Med J (Engl); 2001 Nov; 114(11):1128-31. PubMed ID: 11729503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Classification of disorders of lipid metabolism].
    Richter WO; Schwandt P
    Internist (Berl); 1992 Nov; 33(11):728-31. PubMed ID: 1478827
    [No Abstract]   [Full Text] [Related]  

  • 9. Post-dialysis retention of blood lipoproteins and apolipoproteins in patients with end-stage renal disease on maintenance haemodialysis in Kuwait.
    Al-Rashidi M; Hussain AA; Nampoory MR; Al-Ali JH; Akanji AO
    Clin Chim Acta; 2004 Jun; 344(1-2):149-54. PubMed ID: 15149883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cut points for lipids and lipoproteins in children and adolescents: should they be reassessed?
    Kwiterovich PO
    Clin Chem; 2008 Jul; 54(7):1113-5. PubMed ID: 18593961
    [No Abstract]   [Full Text] [Related]  

  • 11. The concentration of lipids, lipoproteins and apolipoproteins in cord blood serum of newborns in the course of intrauterine period.
    Pac-Kozuchowska E
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):25-32. PubMed ID: 15323161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular biology of hyperlipidemias. Genetic variation of apolipoproteins].
    Novok EM; Bydlowski SP
    Arq Bras Cardiol; 1996 Dec; 67(6):411-7. PubMed ID: 9246831
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter by Ala-Korpela et al regarding article, "Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women".
    Ala-Korpela M; Soininen P; Savolainen MJ
    Circulation; 2009 Oct; 120(17):e149; author reply e150. PubMed ID: 19858422
    [No Abstract]   [Full Text] [Related]  

  • 14. Apolipoprotein E polymorphism and coronary heart disease.
    Ashavaid TF; Todur SP; Nair KG
    J Assoc Physicians India; 2003 Aug; 51():784-8. PubMed ID: 14651139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of chronic alcohol abuse on the lipids, lipoproteins and apolipoproteins concentrations in the sera].
    Krawiec A; Cylwik B; Chrostek L; Supronowicz Z; Szmitkowski M
    Pol Merkur Lekarski; 2008 Jun; 24(144):521-5. PubMed ID: 18702334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel apolipoprotein E5 variant with a 24-bp insertion causing hyperlipidemia.
    Yamanouchi Y; Takano T; Hamaguchi H; Tokunaga K
    J Hum Genet; 2001; 46(11):633-9. PubMed ID: 11721882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of polymorphisms in the apolipoprotein AI-CIII-AIV cluster to hyperlipidaemia in patients with gout.
    Cardona F; Tinahones FJ; Collantes E; Escudero A; García-Fuentes E; Soriguer FJ
    Ann Rheum Dis; 2005 Jan; 64(1):85-8. PubMed ID: 15115711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of adrenocorticotrophic hormone and an equivalent dose of cortisol on the serum concentrations of lipids, lipoproteins, and apolipoproteins.
    Berg AL; Rafnsson AT; Johannsson M; Dallongeville J; Arnadottir M
    Metabolism; 2006 Aug; 55(8):1083-7. PubMed ID: 16839845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hereditary diseases with lipid metabolism disorders].
    Feldioreanu T; Căpraru E; Simu F
    Pediatria (Bucur); 1966; 15(6):521-8. PubMed ID: 5341051
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.